Linked Life Data

9628570

Source:http://linkedlifedata.com/resource/pubmed/id/9628570

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1998-8-27
pubmed:abstractText
Severe allograft coronary artery disease is a significant cause of death in heart transplant recipients. Percutaneous revascularization has thus far been attempted with balloon angioplasty and, to a lesser extent, with directional atherectomy. The new, investigational, solid-state pulsed-wave mid-infrared laser (holmium:YAG) can vaporize and remove atheromatous and thrombotic plaques. This mechanism of plaque ablation may be useful for allograft coronary artery disease associated with focal stenoses deemed unsuitable for standard balloon angioplasty, especially thrombus-containing lesions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1053-2498
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
505-10
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Application of solid-state pulsed-wave, mid-infrared laser for percutaneous revascularization in heart transplant recipients.
pubmed:affiliation
Division of Cardiology, McGuire VA Medical Center, Medical College of Virginia, Virginia Commonwealth University, Richmond 23249, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.